Background Increasing evidence suggests that angiotensin converting enzyme (ACE)
inhibitors exert antithrombotic effects. Based on the assumption of differential effects of …

Background Although specific antiplatelet drugs are well-established and effective in
atherosclerosis prevention, recent clinical trials have also shown that use of angiotensin …

Aim: Cardiovascular events associated with hypertension often involve thrombosis.
Increased platelet activity is one of the risk factors of cardiovascular diseases. Antithrombotic …

Hypertension is associated with decreased fibrinolytic potential, mainly expressed as
elevated plasma plasminogen activator inhibitor type 1 (PAI-1) levels, and increased platelet …

Introduction The interaction between anticoagulants and platelet function is complex.
Previous publications showed mixed results regarding the role of heparins in platelet …

The angiotensin II receptor, losartan, has been found to inhibit platelet aggregability to some
extent in in vitro experiments. There have been conflicting results about the in vivo effects of …

In EUROPA, the angiotensin-converting enzyme inhibitor (ACEI) perindopril on top of other
preventative therapies reduced the risk of major coronary events (cardiovascular death …

Objectives: We sought to investigate, during a two-year follow-up period, the effects of
aspirin on platelet aggregation. Background: The platelets of patients given aspirin may be …

Many studies in recent years have dealt with the use of angiotensin converting enzyme
(ACE) inhibitors for the treatment of ischemic heart disease. The renin-angiotensin system is …

Materials and Methods A total of 60 subjects were included in this observational pilot study
conducted in the medicine out patient department of JJM Hospital, Davanagere, Karnataka …